BackgroundThe coronavirus disease of 2019 was spread all over the world, while diabetes mellitus (DM) remains the most prevalent chronic disease worldwide.
AimsThis study aims to investigate the effect of COVID-19 on glycemic control, insulin resistance (IR), and pH in elderly patients with type 2 diabetes.
MethodsA retrospective study was conducted on patients with type 2 DM who were diagnosed with COVID-19 infection in the central hospitals of the Tabuk region. Patient data were collected from September 2021 to August 2022. Four non-insulin-based insulin resistance indexes were calculated for patients: the triglyceride-glucose (TyG) index, the triglyceride glucose-body mass index (TyG-BMI) index, the triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio, and the metabolic score for insulin resistance (METS-IR).
ResultsPatients showed increased serum fasting glucose and blood HbA1c associated with a high TyG index, TyG-BMI index, TG/HDL ratio, and METS-IR as compared with results before COVID-19. Moreover, during COVID-19, patients revealed a reduction in pH, associated with a reduction in cBase and bicarbonate, and an elevation in PaCO 2 as compared with their results before COVID-19. After complete remission, all patients' results turn back to their level before COVID-19.
ConclusionsPatients with type 2 DM who catch the COVID-19 infection suffer from dysregulation of glycemic control and elevated insulin resistance associated with a significant reduction in their pH.Categories: Endocrinology/Diabetes/Metabolism Keywords: metabolic score for insulin resistance (mets-ir), triglyceride to high-density lipoprotein cholesterol ratio (tg/hdl-c), triglyceride glucose-bmi (tyg-bmi), triglyceride-glucose index (tyg), covid-19